HUP0001826A3 - Thrombin inhibitors - Google Patents

Thrombin inhibitors

Info

Publication number
HUP0001826A3
HUP0001826A3 HU0001826A HUP0001826A HUP0001826A3 HU P0001826 A3 HUP0001826 A3 HU P0001826A3 HU 0001826 A HU0001826 A HU 0001826A HU P0001826 A HUP0001826 A HU P0001826A HU P0001826 A3 HUP0001826 A3 HU P0001826A3
Authority
HU
Hungary
Prior art keywords
thrombin inhibitors
thrombin
inhibitors
Prior art date
Application number
HU0001826A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HUP0001826A2 publication Critical patent/HUP0001826A2/hu
Publication of HUP0001826A3 publication Critical patent/HUP0001826A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
HU0001826A 1996-08-14 1997-07-29 Thrombin inhibitors HUP0001826A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19632773A DE19632773A1 (de) 1996-08-14 1996-08-14 Neue Thrombininhibitoren
PCT/EP1997/004104 WO1998006741A1 (de) 1996-08-14 1997-07-29 Thrombininhibitoren

Publications (2)

Publication Number Publication Date
HUP0001826A2 HUP0001826A2 (hu) 2000-09-28
HUP0001826A3 true HUP0001826A3 (en) 2002-01-28

Family

ID=7802624

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001826A HUP0001826A3 (en) 1996-08-14 1997-07-29 Thrombin inhibitors

Country Status (30)

Country Link
US (1) US6114358A (hu)
EP (1) EP0956294B1 (hu)
JP (1) JP4089981B2 (hu)
KR (1) KR20000030002A (hu)
CN (1) CN1228783A (hu)
AR (1) AR009070A1 (hu)
AT (1) ATE268781T1 (hu)
AU (1) AU735364B2 (hu)
BG (1) BG103096A (hu)
BR (1) BR9711191A (hu)
CA (1) CA2263220A1 (hu)
CO (1) CO4900030A1 (hu)
CZ (1) CZ299634B6 (hu)
DE (2) DE19632773A1 (hu)
DK (1) DK0956294T3 (hu)
ES (1) ES2221062T3 (hu)
HR (1) HRP970441B1 (hu)
HU (1) HUP0001826A3 (hu)
ID (1) ID17873A (hu)
IL (1) IL127751A0 (hu)
MY (1) MY132820A (hu)
NO (1) NO990662D0 (hu)
NZ (1) NZ333679A (hu)
PL (1) PL188411B1 (hu)
PT (1) PT956294E (hu)
RU (1) RU2175328C2 (hu)
SK (1) SK284915B6 (hu)
TR (1) TR199900310T2 (hu)
WO (1) WO1998006741A1 (hu)
ZA (1) ZA977239B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
EP1049673A1 (de) * 1998-01-26 2000-11-08 Basf Aktiengesellschaft Heterocyclische amidine als kallikrein protease inhibitoren
CN1289341A (zh) * 1998-01-26 2001-03-28 Basf公司 凝血酶抑制剂
CA2321025A1 (en) * 1998-02-09 1999-08-12 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
PL351767A1 (en) * 1999-02-09 2003-06-16 Dimensional Pharmaceuticals 3 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
HUP0203167A3 (en) * 1999-04-09 2003-09-29 Basf Ag Peptidic substances, their preparations and their use as complement protease inhibitors
BR0009674A (pt) 1999-04-09 2002-01-15 Basf Ag Composto, droga, e, uso de composto
AU3559000A (en) * 1999-04-09 2000-11-14 Basf Aktiengesellschaft Method for producing amidines
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
KR20010002891A (ko) * 1999-06-18 2001-01-15 성재갑 아릴 또는 헤테로아릴 그룹을 갖는 트롬빈 억제제 및 그 제조 방법
DE19933861A1 (de) * 1999-07-23 2001-01-25 Basf Ag Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
FI122575B (fi) 2006-12-04 2012-03-30 Dieffenbacher Panelboard Oy Laitteisto kuitujen, kuten lastujen sirottelemiseksi
KR101955691B1 (ko) 2010-03-30 2019-03-07 베르선 코포레이션 트롬빈 억제제로서의 다중치환된 방향족 화합물
RU2019101889A (ru) 2013-03-15 2019-03-28 Версеон Корпорейшн Полизамещенные ароматические соединения в качестве ингибиторов сериновых протеаз
CN105209440B (zh) 2013-03-15 2019-07-23 维颂公司 作为凝血酶抑制剂的卤代吡唑
CN103520160B (zh) * 2013-10-17 2015-04-22 广东药学院 三棱中肽类化合物的应用
CA2960790A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
US10532995B2 (en) 2015-02-27 2020-01-14 Verseon Corporation Substituted pyrazole compounds as serine protease inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
WO1996025426A1 (de) * 1995-02-17 1996-08-22 Basf Aktiengesellschaft Neue dipeptidische amidine als thrombin-inhibitoren
DE19632772A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren

Also Published As

Publication number Publication date
KR20000030002A (ko) 2000-05-25
IL127751A0 (en) 1999-10-28
PL188411B1 (pl) 2005-01-31
AR009070A1 (es) 2000-03-08
ATE268781T1 (de) 2004-06-15
AU3941797A (en) 1998-03-06
DE59711714D1 (de) 2004-07-15
PT956294E (pt) 2004-10-29
RU2175328C2 (ru) 2001-10-27
MY132820A (en) 2007-10-31
DK0956294T3 (da) 2004-10-11
CZ48699A3 (cs) 1999-05-12
SK284915B6 (sk) 2006-02-02
PL331540A1 (en) 1999-07-19
EP0956294A1 (de) 1999-11-17
HRP970441A2 (en) 1998-06-30
EP0956294B1 (de) 2004-06-09
US6114358A (en) 2000-09-05
BR9711191A (pt) 1999-08-17
ES2221062T3 (es) 2004-12-16
NO990662L (no) 1999-02-12
DE19632773A1 (de) 1998-02-19
NO990662D0 (no) 1999-02-12
ID17873A (id) 1998-02-05
TR199900310T2 (xx) 1999-04-21
CO4900030A1 (es) 2000-03-27
JP2000516598A (ja) 2000-12-12
AU735364B2 (en) 2001-07-05
ZA977239B (en) 1999-02-15
NZ333679A (en) 1999-09-29
JP4089981B2 (ja) 2008-05-28
HUP0001826A2 (hu) 2000-09-28
CN1228783A (zh) 1999-09-15
SK899A3 (en) 1999-06-11
WO1998006741A1 (de) 1998-02-19
CZ299634B6 (cs) 2008-10-01
BG103096A (en) 1999-09-30
CA2263220A1 (en) 1998-02-19
HRP970441B1 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
EP0927035A4 (en) THROMBIN INHIBITORS
EP0969840A4 (en) THROMBIN INHIBITORS
EP0820453A4 (en) THROMBIN INHIBITORS
HRP960075B1 (en) New thrombin inhibitors
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
EP0923372A4 (en) PYRIDINONE THROMBINE INHIBITORS
EP1124822A4 (en) THROMBIN INHIBITORS
HUP0001826A3 (en) Thrombin inhibitors
EP0971891A4 (en) THROMBIN INHIBITORS
PL328307A1 (en) Serinic protease inhibitors
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL328875A1 (en) Serinic protease inhibitors
EP1117660A4 (en) THROMBIN INHIBITORS
PL328223A1 (en) Aspartil protease inhibitors
IL136139A0 (en) Thrombin inhibitors
AU3396697A (en) Thrombin inhibitor
GB9613718D0 (en) Thrombin inhibitors
ZA974779B (en) Thrombin inhibitors.
IL121474A0 (en) Thrombin inhibitors
EP1017383A4 (en) THROMBIN INHIBITORS
EP1039907A4 (en) THROMBIN INHIBITORS
EP1027333A4 (en) THROMBIN INHIBITORS
GB9624319D0 (en) Thrombin inhibitors
GB9605163D0 (en) Thrombin inhibitors
GB9624278D0 (en) Thrombin inhibitors